Korean J Hematol 2001; 36(3):

Published online September 30, 2001

© The Korean Society of Hematology

급성 면역성혈소판감소성자반증 환아에서의 저용량 단기간 정주용 감마글로불린의 효과(2)

이건수

경북대학교 의과대학 소아과학교실

Low-dose and Short-term Therapy of Intravenous Immunoglobulin G for Childhood Acute Immune Thrombocytopenic Purpura(2)

Kun Soo Lee

Department of Pediatrics, Kyungpook National University School of Medicine, Taegu, Korea

Abstract

Background:
We reported the results of low-dose and short-term intravenous immnuoglobulin G (IVIG) therapy to raise the platelet count over 100,000/㎣ for childhood acute idiopathic thrombocytopenic purpura (ITP) according to the
individual clinical response. The effects had no differences in two groups between low-dose and full-dose. This study was conducted to compare the recurrence rate and chronicity in patients who were given IVIG according to the individual clinical course until the platelet counts over 50,000/㎣.
Methods:
The low-dose and short-term IVIG therapy (400㎎/㎏/day) until rising the platelet counts over 50,000/㎣ was attempted in 68 childhood ITP who were diagnosed at the Department of Pediatrics, Kyungpook National University Hospital from September, 1993 to April, 2001. The patients rising the platelet counts over 50,000/㎣ after 1∼2, 3∼4, and 5 or more doses of IVIG were defined a rapid, intermediate and slow responder (RR, IR, and SR).
Results:
The median age was 3.2 years and male to female ratio was 2.6:1 and the median duration of follow up was 2.1 years. Among 47 cases who were followed up over 6 months, 14 cases (29.8%) were into chronic ITP. The days of IVIG therapy
was one in 10, two in 19, three in 17, four in 7, five in 5, six in 3, seven in 1, eight in 3, nine in 1, twelve in 1 and fourteen in one children. The median platelet counts was 16,180±10,309/㎣ at diagnosis and was increased to 36,164±27,570/㎣ after 1 day, 76,076±56,463/㎣ after 2 days, 107,470±68,236/㎣ after 3 days, 95,814±52,473/㎣ after 4 days and 109,850±56,785/㎣ after 5 days of IVIG therapy. But the platelet count was not increased above 100,000/㎣ in 7 cases among those who were given over 4 days or more IVIG therapy. The platelet counts began to rise above 50,000/㎣ at 2.9 days, 100,000/㎣ at 4.0 days and 150,000/㎣ at 4.6 days of IVIG therapy. Four of 29 RR, 5 of 24 IR and 7 of 15 SR were relapsed (P value of RR vs SR=0.028). Seven of 28 RR, 1 of 11 IR and 6 of 8 SR became a chronic type (P value of RR vs SR=0.016, IR vs SR=0.006).
Conclusion:
The low-dose and short-term IVIG according to the individual clinical response may be a desirable method for the treatment of childhood acute ITP.

Keywords Immune thrombocytopenic pur-pura, Childhood, Intravenous immnuoglobulin G, Low-dose, Short-term

Article

Korean J Hematol 2001; 36(3): 247-252

Published online September 30, 2001

Copyright © The Korean Society of Hematology.

급성 면역성혈소판감소성자반증 환아에서의 저용량 단기간 정주용 감마글로불린의 효과(2)

이건수

경북대학교 의과대학 소아과학교실

Low-dose and Short-term Therapy of Intravenous Immunoglobulin G for Childhood Acute Immune Thrombocytopenic Purpura(2)

Kun Soo Lee

Department of Pediatrics, Kyungpook National University School of Medicine, Taegu, Korea

Abstract

Background:
We reported the results of low-dose and short-term intravenous immnuoglobulin G (IVIG) therapy to raise the platelet count over 100,000/㎣ for childhood acute idiopathic thrombocytopenic purpura (ITP) according to the
individual clinical response. The effects had no differences in two groups between low-dose and full-dose. This study was conducted to compare the recurrence rate and chronicity in patients who were given IVIG according to the individual clinical course until the platelet counts over 50,000/㎣.
Methods:
The low-dose and short-term IVIG therapy (400㎎/㎏/day) until rising the platelet counts over 50,000/㎣ was attempted in 68 childhood ITP who were diagnosed at the Department of Pediatrics, Kyungpook National University Hospital from September, 1993 to April, 2001. The patients rising the platelet counts over 50,000/㎣ after 1∼2, 3∼4, and 5 or more doses of IVIG were defined a rapid, intermediate and slow responder (RR, IR, and SR).
Results:
The median age was 3.2 years and male to female ratio was 2.6:1 and the median duration of follow up was 2.1 years. Among 47 cases who were followed up over 6 months, 14 cases (29.8%) were into chronic ITP. The days of IVIG therapy
was one in 10, two in 19, three in 17, four in 7, five in 5, six in 3, seven in 1, eight in 3, nine in 1, twelve in 1 and fourteen in one children. The median platelet counts was 16,180±10,309/㎣ at diagnosis and was increased to 36,164±27,570/㎣ after 1 day, 76,076±56,463/㎣ after 2 days, 107,470±68,236/㎣ after 3 days, 95,814±52,473/㎣ after 4 days and 109,850±56,785/㎣ after 5 days of IVIG therapy. But the platelet count was not increased above 100,000/㎣ in 7 cases among those who were given over 4 days or more IVIG therapy. The platelet counts began to rise above 50,000/㎣ at 2.9 days, 100,000/㎣ at 4.0 days and 150,000/㎣ at 4.6 days of IVIG therapy. Four of 29 RR, 5 of 24 IR and 7 of 15 SR were relapsed (P value of RR vs SR=0.028). Seven of 28 RR, 1 of 11 IR and 6 of 8 SR became a chronic type (P value of RR vs SR=0.016, IR vs SR=0.006).
Conclusion:
The low-dose and short-term IVIG according to the individual clinical response may be a desirable method for the treatment of childhood acute ITP.

Keywords: Immune thrombocytopenic pur-pura, Childhood, Intravenous immnuoglobulin G, Low-dose, Short-term

Blood Res
Volume 59 2024

Stats or Metrics

Share this article on

  • line

Related articles in BR

Blood Research

pISSN 2287-979X
eISSN 2288-0011
qr-code Download